β-Ionone promotes ferroptosis of human gastric cancer cells by inhibiting the Wnt/β-catenin pathway in vitro and in vivo
Pathology - Research and Practice · 2025
DOI: 10.1016/j.prp.2025.156180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Ting-Ting Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The 4th Affiliated Hospital of Harbin Medical University, 37 Yi-Yuan Street, Nangang District, Harbin 150001, Chin…. Hauptthemen laut MEDLINE: Ferroptosis, Stomach Neoplasms, Wnt Signaling Pathway, Norisoprenoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Harbin Medical University.
Abstract (Originalsprache)
β-Ionone (BI) has shown the potent inhibitory malignant progression of multiple tumors including gastric cancer in vitro and in vivo. However, the mechanism by which BI inhibits gastric cancer remains to be clarified, especially in ferroptosis, which is a new form of programmed cell death. The aim of this study was to investigate whether BI could induce ferroptosis in gastric cancer and the underlying mechanisms. The results manifested that BI obviously inhibited cell viability and increased the Fe2 + level, total reactive oxygen species (ROS) and lipid ROS levels and the malondialdehyde (MDA) concentrations, but reduced the mitochondrial membrane potential (MMP) and the expression of SLC7A11 and GPX4 in MKN45 cells and AGS cells (P < 0.05 or P < 0.01). Besides, BI also arrested cell cycle and decreased the expression of Cyclin D1 and CDK4 (P < 0.05 or P < 0.01). Mechanistically, BI reduced the levels of β-catenin and pGSK-3β/GSK-3β in MKN45 cells and AGS cells (P < 0.05 or P < 0.01). Nevertheless, pretreatment with lithium chloride (LiCl), an inhibitor of GSK-3β, reversed BI-induced ferroptosis and cell cycle arrested in MKN45 cells (P < 0.05). In addition, BI effectively inhibited the growth of gastric cancer xenografts and downregulated the levels of GPX4, SLC7A11, PCNA, β-catenin and pGSK-3β/GSK-3β (P < 0.05 or P < 0.01). Collectively, our study reveals that BI inhibits proliferation of gastric cancer cells by induction ferroptosis via the Wnt/β-catenin signaling pathway and provides a novel therapy for gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The 4th Affiliated Hospital of Harbin Medical University, 37 Yi-Yuan Street, Nangang District, Harbin 150001, China.
- Department of Endoncrology, The 2nd Affiliated Hospital of Harbin Medical University, 246 Xuefu Road, NanGang District, Harbin 150081, China.
- College of Public Health, Harbin Medical University, 157 Baojian Road, NanGang District, Harbin 150081, China.
- Department of Clinical Laboratory, The 4th Affiliated Hospital of Harbin Medical University, 37 Yi-Yuan Street, Nangang District, Harbin 150001, China; Heilongjiang Research Center of Molecular Medicine Engineering Tech…
Förderung
- National Natural Science Foundation of China
- Harbin Medical University
Zitieren
APA
Yang, T. T., Ma, X. X., Zhang, X., Han, Z. Q., Zhang, S., Wang, Q., Dong, H. W., & Liu, J. R. (2025). β-Ionone promotes ferroptosis of human gastric cancer cells by inhibiting the Wnt/β-catenin pathway in vitro and in vivo. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.156180
Vancouver
Yang TT, Ma XX, Zhang X, Han ZQ, Zhang S, Wang Q, et al. β-Ionone promotes ferroptosis of human gastric cancer cells by inhibiting the Wnt/β-catenin pathway in vitro and in vivo. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.156180
BibTeX
@article{Yang2025,
author = {Yang, Ting-Ting and Ma, Xin-Xin and Zhang, Xuan and Han, Zhen-Qing and Zhang, Shuang and Wang, Qi and Dong, Hong-Wei and Liu, Jia-Ren},
title = {β-Ionone promotes ferroptosis of human gastric cancer cells by inhibiting the Wnt/β-catenin pathway in vitro and in vivo},
journal = {Pathology - Research and Practice},
year = {2025},
doi = {10.1016/j.prp.2025.156180}
}
EUVIMED